Wall Street brokerages expect that Cavium Inc (NASDAQ:CAVM) will report $238.92 million in sales for the current quarter, Zacks reports. Six analysts have issued estimates for Cavium’s earnings. The lowest sales estimate is $238.18 million and the highest is $239.33 million. Cavium reported sales of $107.16 million in the same quarter last year, which indicates a positive year over year growth rate of 123%. The business is expected to report its next earnings report on Tuesday, July 25th.

According to Zacks, analysts expect that Cavium will report full year sales of $238.92 million for the current year, with estimates ranging from $967.61 million to $978.66 million. For the next financial year, analysts forecast that the business will post sales of $1.09 billion per share, with estimates ranging from $1.07 billion to $1.13 billion. Zacks’ sales averages are an average based on a survey of analysts that follow Cavium.

Cavium (NASDAQ:CAVM) last issued its quarterly earnings results on Wednesday, April 26th. The semiconductor provider reported $0.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by $0.09. The business had revenue of $229.58 million for the quarter, compared to analyst estimates of $227.22 million. Cavium had a positive return on equity of 2.07% and a negative net margin of 24.40%. The business’s revenue for the quarter was up 125.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.25 earnings per share.

A number of equities analysts have recently issued reports on CAVM shares. Argus raised their price target on Cavium from $75.00 to $82.00 and gave the stock a “buy” rating in a research note on Tuesday, March 14th. Bank of America Corp restated a “buy” rating on shares of Cavium in a research note on Thursday, March 2nd. Needham & Company LLC restated a “buy” rating and issued a $77.00 price target on shares of Cavium in a research note on Monday, February 27th. MKM Partners started coverage on Cavium in a research note on Wednesday, February 22nd. They issued a “buy” rating and a $77.00 price target on the stock. Finally, Zacks Investment Research upgraded Cavium from a “hold” rating to a “buy” rating and set a $75.00 price target on the stock in a research note on Wednesday, February 8th. Eight research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $71.79.

Cavium (NASDAQ:CAVM) opened at 74.21 on Friday. The stock’s 50 day moving average price is $70.87 and its 200-day moving average price is $65.94. Cavium has a 12 month low of $35.90 and a 12 month high of $76.26. The firm’s market capitalization is $5.04 billion.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/05/27/238-92-million-in-sales-expected-for-cavium-inc-cavm-this-quarter.html.

In other news, VP Arthur D. Chadwick sold 63,813 shares of the business’s stock in a transaction dated Wednesday, March 8th. The stock was sold at an average price of $69.76, for a total value of $4,451,594.88. Following the transaction, the vice president now directly owns 95,383 shares in the company, valued at $6,653,918.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Vincent P. Pangrazio sold 15,000 shares of the business’s stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $75.73, for a total value of $1,135,950.00. Following the completion of the transaction, the senior vice president now owns 60,039 shares in the company, valued at $4,546,753.47. The disclosure for this sale can be found here. Insiders sold 118,813 shares of company stock worth $8,593,145 over the last 90 days. Company insiders own 4.63% of the company’s stock.

Several institutional investors have recently made changes to their positions in the stock. Tributary Capital Management LLC acquired a new position in shares of Cavium during the third quarter valued at approximately $1,497,000. Jane Street Group LLC increased its position in shares of Cavium by 12,309.0% in the third quarter. Jane Street Group LLC now owns 36,627 shares of the semiconductor provider’s stock valued at $2,132,000 after buying an additional 36,927 shares during the last quarter. Empyrean Capital Partners LP acquired a new position in shares of Cavium during the third quarter valued at approximately $6,932,000. Irving Magee Investment Management acquired a new position in shares of Cavium during the third quarter valued at approximately $2,835,000. Finally, Avalon Global Asset Management LLC increased its position in shares of Cavium by 8.2% in the third quarter. Avalon Global Asset Management LLC now owns 65,700 shares of the semiconductor provider’s stock valued at $3,824,000 after buying an additional 5,000 shares during the last quarter.

Cavium Company Profile

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

12 Month Chart for NASDAQ:CAVM

Get a free copy of the Zacks research report on Cavium (CAVM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cavium Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc and related companies with MarketBeat.com's FREE daily email newsletter.